These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10980325)

  • 21. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG; Browning JL; Young KA; Hicks PB
    Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dependence of the antagonism at human platelet 5-HT2 receptors by ketanserin on the reaction pH.
    De Clerck F; Xhonneux B; Tollenaere JP; Janssen PA
    Thromb Res; 1985 Dec; 40(5):581-96. PubMed ID: 2935970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery.
    Geerts IS; Matthys KE; Herman AG; Bult H
    Br J Pharmacol; 1999 Jul; 127(6):1327-36. PubMed ID: 10455282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study.
    Matsumoto I; Inoue Y; Iwazaki T; Pavey G; Dean B
    Neurosci Lett; 2005 May; 379(3):164-8. PubMed ID: 15843056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
    J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Flupenthixol--a partial atypical neuroleptic?].
    Kühn KU; Meyer K; Maier W
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S38-41. PubMed ID: 10907612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene.
    Lane HY; Chang YC; Chiu CC; Chen ML; Hsieh MH; Chang WH
    Am J Psychiatry; 2002 Sep; 159(9):1593-5. PubMed ID: 12202283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.
    Schächter M; Geaney DP; Grahame-Smith DG; Cowen PJ; Elliott JM
    Br J Clin Pharmacol; 1985 Apr; 19(4):453-7. PubMed ID: 2859873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine(2A) receptor.
    Hanley NR; Hensler JG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):468-77. PubMed ID: 11805206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia.
    Rasmussen H; Erritzoe D; Andersen R; Ebdrup BH; Aggernaes B; Oranje B; Kalbitzer J; Madsen J; Pinborg LH; Baaré W; Svarer C; Lublin H; Knudsen GM; Glenthoj B
    Arch Gen Psychiatry; 2010 Jan; 67(1):9-16. PubMed ID: 20048218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collar-induced elevation of mRNA and functional activity of 5-HT(1B) receptor in the rabbit carotid artery.
    Geerts IS; De Meyer GR; Bult H
    Br J Pharmacol; 2000 Dec; 131(8):1723-31. PubMed ID: 11139452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet serotonin concentrations in medicated schizophrenic patients.
    Kaneda Y; Fujii A; Nagamine I
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jul; 25(5):983-92. PubMed ID: 11444685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine.
    Munzar P; Justinova Z; Kutkat SW; Goldberg SR
    Eur J Pharmacol; 2002 Feb; 436(1-2):75-82. PubMed ID: 11834249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketanserin attenuates the behavioural effects of corticosterone: implications for 5-HT(2A) receptor regulation.
    Gorzalka BB; Hanson LA; Hong JJ
    Eur J Pharmacol; 2001 Oct; 428(2):235-40. PubMed ID: 11675041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
    Remington G; Kapur S
    J Clin Psychiatry; 1999; 60 Suppl 10():15-9. PubMed ID: 10340683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT2A receptor antagonist properties of cyamemazine in rat and guinea pig smooth muscle.
    Alvarez-Guerra M; Hameg A; Bayle F; Dib M; Garay RP
    Eur J Pharmacol; 2002 Nov; 454(2-3):235-9. PubMed ID: 12421652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.
    Seyrek M; Kahraman S; Deveci MS; Yesilyurt O; Dogrul A
    Eur J Pharmacol; 2010 Dec; 649(1-3):183-94. PubMed ID: 20868676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.